|
ANP32E expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.84490000004956E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79389999999113E-05 |
| Normal-vs-Stage2 |
1.202060E-04 |
| Normal-vs-Stage3 |
5.034200E-04 |
| Normal-vs-Stage4 |
7.613600E-01 |
| Stage1-vs-Stage2 |
6.746600E-01 |
| Stage1-vs-Stage3 |
5.405200E-01 |
| Stage1-vs-Stage4 |
9.688000E-02 |
| Stage2-vs-Stage3 |
3.777000E-01 |
| Stage2-vs-Stage4 |
2.078000E-01 |
| Stage3-vs-Stage4 |
3.299800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.50659999995384E-06 |
| Normal-vs-AfricanAmerican |
5.75099999999829E-05 |
| Normal-vs-Asian |
4.003700E-02 |
| Caucasian-vs-AfricanAmerican |
9.426400E-01 |
| Caucasian-vs-Asian |
9.009400E-01 |
| AfricanAmerican-vs-Asian |
8.955000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88420000046818E-07 |
| Normal-vs-Female |
2.127800E-02 |
| Male-vs-Female |
3.726400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.363440E-01 |
| Normal-vs-Extreme_Weight |
4.30900004566581E-09 |
| Normal-vs-Obese |
5.84739999999195E-05 |
| Normal-vs-Extreme_Obese |
3.598100E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.097800E-02 |
| Normal_Weight-vs-Obese |
3.017400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.592100E-02 |
| Extreme_Weight-vs-Obese |
9.384300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.859200E-01 |
| Obese-vs-Extreme_Obese |
2.962400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.497000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.180300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.90449999995612E-06 |
| Normal-vs-Age(81-100Yrs) |
8.07650000000937E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.644200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.020000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.231360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.117000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.734100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.578200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.73546999999719E-05 |
| Normal-VS-Type2 PRCC |
1.77670000000019E-05 |
| Normal-VS-KIRP CIMP |
1.828030E-01 |
| Normal-VS-Unclassified PRCC |
3.8201000000071E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.961600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.763800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.465600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.230850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.676200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.181360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.44189999939925E-08 |
| Normal-vs-N1 |
4.865000E-01 |
| Normal-vs-N2 |
8.166300E-02 |
| N0-vs-N1 |
1.924470E-02 |
| N0-vs-N2 |
1.557060E-04 |
| N1-vs-N2 |
8.189000E-01 |
|
|
